A review of agents in late-stage development as of March 2008 for the treatment of diabetic retinopathy, dry eye syndrome, macular degeneration, and diabetic macular edema

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Drug Watch: Agents in late-stage development for the treatment of selected ophthalmic disorders (March 2008) (PDF)

Newsletter